Zobrazeno 1 - 10
of 38
pro vyhledávání: '"J. P. Demarez"'
Autor:
Evelyne Jacqz-Aigrain, Véronique Lamarque, E. Autret-Leca, L. Becquemont, M.-J. Boutroy, P. Carlier, A. Castot, C. Cornu, C. Damase-Michel, J.-P. Demarez, E. Dohin, M. Gersberg, C. Kreft-Jais, H. Le Louet, F. Meillier, J.-L. Parier, G. Pons, D. Subtil, T. Vial
Publikováno v:
Therapies. 61:297-304
Data required to asses the risk of a new drug regarding the normal course of pregnancy as well as embryo, fetal and neonate development, are often missing when a new product is launched. In such a situation, a risk management plan is to be developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61ab067ec4d86409625c8a8de179ace
https://doi.org/10.2515/therapie:2006057
https://doi.org/10.2515/therapie:2006057
Autor:
Evelyne Jacqz-Aigrain, Véronique Lamarque, E. Autret-Leca, L. Becquemont, M.-J. Boutroy, P. Carlier, A. Castot, C. Cornu, C. Damase-Michel, J.-P. Demarez, E. Dohin, M. Gersberg, C. Kreft-Jais, H. Le Louet, F. Meillier, J.-L. Parier, G. Pons, D. Subtil, T. Vial
Publikováno v:
Therapies. 61:287-295
Resume Les donnees evaluant le risque d’un nouveau produit sur le deroulement normal de la grossesse et le developpement de l’embryon, du fœtus et du nouveau-ne sont le plus souvent manquantes lors de la mise sur le marche d’un nouveau produit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cb12ea5cd9cf3d99dd3e6f1c0bcd308
https://doi.org/10.2515/therapie:2006056
https://doi.org/10.2515/therapie:2006056
Autor:
Chantal Bélorgey, Yannick Plétan, Jean-Marie Goehrs, F. Berger, P.-H. Bertoye, N. Brion, A. Buntix, H. Caplain, C. Caulin, S. Courcier-Duplantier, V. Daurat, J.-P. Demarez, B. Diquet, M. Echemann, C. Funck-Brentano, V. Lamarque, S. Laurent, C. Libersa, C. Marey, N. Moore, A. Patat, J.-L. Pinquier, J.-C. Reynier, A. Sawaya, C. Sibenaler, N. Simon, D. Tremblay, P. Vella, D. Warot
Publikováno v:
Therapies. 59:337-347
The European Directive on clinical trials of medicinal products will fall within the scope of the legislation of Member States on 1 May 2004. In France, this adaptation will be carried out by a public health bill concerning, among other things, the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87033289c6a940b221ba96298b769cd5
https://doi.org/10.2515/therapie:2004063
https://doi.org/10.2515/therapie:2004063
Autor:
Chantal Bélorgey, Yannick Plétan, Jean-Marie Goehrs, F. Berger, P.-H. Bertoye, N. Brion, A. Buntix, H. Caplain, C. Caulin, S. Courcier-Duplantier, V. Daurat, J.-P. Demarez, B. Diquet, M. Echemann, C. Funck-Brentano, V. Lamarque, S. Laurent, C. Libersa, C. Marey, N. Moore, A. Patat, J.-L. Pinquier, J.-C. Reynier, A. Sawaya, C. Sibenaler, N. Simon, D. Tremblay, P. Vella, D. Warot
Publikováno v:
Therapies. 59:329-336
Resume La Directive Europeenne Essais Cliniques des medicaments devra entrer dans le droit des etats membres le 1 er mai 2004. En France, c’est par un projet de loi de Sante Publique portant entre autres sur la reforme de l’actuelle loi Huriet-Se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c37db1a41586a8e0f5fdbb961f93789d
https://doi.org/10.2515/therapie:2004062
https://doi.org/10.2515/therapie:2004062
Publikováno v:
Therapie. 57(4)
Fourteen years after the concept was created, it seemed important to assess how well investigators actually apply Good Clinical Practice. Various sources of information have revealed a general deficiency in their application: "investigation by the wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::248346a36e7adda7adc9be649ca47848
https://pubmed.ncbi.nlm.nih.gov/12422554
https://pubmed.ncbi.nlm.nih.gov/12422554
Autor:
J P, Demarez
Publikováno v:
Therapie. 57(2)
An institutional pharmacovigilance specialist gives advice only when consulted by a prescribing physician about a pregnant woman. The situation may involve a pregnant woman for whom a prescription may be considered or a pregnant woman for whom a pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b84fee74c950068164cc2b051a77d84f
https://pubmed.ncbi.nlm.nih.gov/12185969
https://pubmed.ncbi.nlm.nih.gov/12185969
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Therapie. 50(4)
In a workshop held in Giens in September 1994, representatives of drug companies and scientists met to discuss the place of women in clinical trials. They recommend that, in phase II and III studies, men and women should be included in a proportion e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dea38f0a98fad855d6100e3cbb803a81
https://pubmed.ncbi.nlm.nih.gov/7482390
https://pubmed.ncbi.nlm.nih.gov/7482390
Autor:
J. P. Demarez, M. Ansseau, Arlette Lecoq, S. Koch-Bourdouxhe, Patrick Papart, R. von Frenckell, P. Darimont, C. Serre, Louis Botte, C. Mertens, J. De Wilde, J. M. Devoitille, J. Mirel, J. L. Evrard, Jean-Pierre Couzinier, A. De Nayer
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 4:221-227
A multicentre study compared the antidepressant efficacy and the tolerance of milnacipran (200 mg/d) and amitriptyline (150 mg/d) in two parallel groups of 43 major depressive inpatients, endogenous subtype, as defined by Research Diagnostic Criteria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f7249036156b89cd78aa4d4848578e0
https://doi.org/10.1002/hup.470040308
https://doi.org/10.1002/hup.470040308
Autor:
J P, Demarez, J P, Couzinier
Publikováno v:
Acta medicinae legalis et socialis. 32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ab19794439064b412b1fee31299835f
https://pubmed.ncbi.nlm.nih.gov/7183148
https://pubmed.ncbi.nlm.nih.gov/7183148